News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
La sede de Oryzon
ORYZON reports financial results and corporate update for half-year ending June 30, 2025
Healthcare
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0…
Partners - Oryzon Genomics
ronda en Capital Cell: Mikrobiomik.
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Healthcare · Access to innovation
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Partners - Mikrobiomik
Científica observando a través de un microscopio
New technology detects breast cancer relapse up to five years before symptoms appear using blood samples
Healthcare · Personalized medicine
A study led by Dr. Iñaki Comino-Méndez and Dr. Emilio Alba from the Hospital Universitario Virgen…
Partners - Altum Sequencing
Clesa Innovation Center en Madrid
Kadans presents its new space for innovation in life sciences: Clesa Innovation Center
Healthcare
Located in the heart of biomedical innovation in Madrid, and with an investment of over 35 million…
Partners - KADANS SCIENCE PARTNER 1 SP S.L.
Miquel A. Bru, Cofounder & CBDO de Genomcore
#NewAseBioMember | “AseBio represents the meeting point of Spain’s biotechnology ecosystem”
Corporate
Meet our new member, Genomcore. We spoke with Miquel A. Bru, Cofounder & CBDO.
AseBio - GENOMCORE
Ricardo Inaci, BioDuro
#NewAseBioMember | “AseBio is a valuable platform for collaboration, visibility, and shared growth”
Corporate
Meet our new member, BioDuro. We spoke with Ricardo Inacio, Executive Director |…
AseBio - BIODURO
El equipo gestor de Inveready Innvierte Biotech II ha estado liderado por Sara Secall, Roger Piqué y Josep Maria Echarri.
Inveready successfully closes Inveready Innvierte Biotech II, its second life sciences fund
Financing · Corporate
Inveready completes its third venture capital fund with a 4.3x return on capital invested by…
Partners - Inveready
Consejo Informal de Competitividad de la UE
Spain urges the EU to place biotechnology at the core of its Industrial Strategy
Healthcare · Climate change · Agrifood · Industrial biotechnology · International · Financing
At AseBio, we strongly support the proposals put forward by the Minister of Industry and Tourism,…
Gráfica que muestra en un ordenador el crecimiento de una empresa
Expanding analyst interest in ORYZON
Healthcare
New U.S. investment bank joins, bringing total coverage to ten analysts.
Partners - Oryzon Genomics